Omnicell Inc (OMCL)
Cash ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 369,201 | 467,972 | 330,362 | 349,051 | 485,928 |
| Short-term investments | US$ in thousands | 12,475 | 33,007 | 11,486 | 10,665 | 10,246 |
| Total current liabilities | US$ in thousands | 595,678 | 367,792 | 428,446 | 876,158 | 276,423 |
| Cash ratio | 0.64 | 1.36 | 0.80 | 0.41 | 1.79 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($369,201K
+ $12,475K)
÷ $595,678K
= 0.64
Omnicell Inc's cash ratio has experienced fluctuations over the past five years. As of December 31, 2020, the company had a healthy cash ratio of 1.79, indicating that it had sufficient cash or cash equivalents to cover its current liabilities. However, by the end of 2021, the cash ratio had decreased to 0.41, signaling a potential liquidity strain.
In 2022, the cash ratio improved to 0.80, although it remained below the ideal value of 1. This suggests that Omnicell Inc may have faced challenges in managing its short-term obligations efficiently. By the end of 2023, the cash ratio rose significantly to 1.36, reflecting a stronger liquidity position for the company.
Despite the improvement in 2023, the cash ratio dropped again in 2024 to 0.64, indicating a decrease in the company's ability to cover its short-term liabilities with its cash reserves alone. Overall, Omnicell Inc's cash ratio trend indicates variability in its liquidity management over the analyzed period, emphasizing the importance of closely monitoring the company's cash position to ensure sufficient liquidity for operational needs.
Peer comparison
Dec 31, 2024